CERUBIDINE INJECTION 20mg Vial (Daunorubicin)

CERUBIDINE INJECTION 20mg Vial (Daunorubicin)

Prescription only Generic
$131.68
Active Ingredient : Daunorubicin
Meta description: Discover the benefits of CERUBIDINE INJECTION 20mg Vial (Daunorubicin), an effective treatment option for various cancers, designed to enhance patient outcomes and improve overall health.

Reliable shipping

Flexible returns
Dispensing Country : India
Placeholder
Zoomed

CERUBIDINE INJECTION 20mg Vial, containing Daunorubicin, is a potent antineoplastic medication primarily used in the treatment of various types of cancer. This injectable formulation is particularly effective in managing acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and other hematologic malignancies. Daunorubicin works by intercalating DNA and inhibiting topoisomerase II, thereby disrupting cancer cell replication and leading to cell death.



Each vial of CERUBIDINE contains 20mg of Daunorubicin hydrochloride, formulated as a sterile, lyophilized powder for reconstitution. It is administered intravenously by healthcare professionals, ensuring precise dosing and minimizing the risk of adverse effects. The dosage and treatment schedule are tailored to the patient’s condition, requiring careful monitoring of blood counts, liver function, and cardiac health due to potential side effects.



Common side effects of CERUBIDINE include myelosuppression, nausea, vomiting, and hair loss. It may also cause cardiotoxicity, particularly at higher cumulative doses, necessitating regular cardiac evaluations during treatment. Patients should be monitored for signs of infection, bleeding, or unusual fatigue, as these may indicate complications requiring immediate medical attention.



CERUBIDINE is contraindicated in patients with pre-existing heart conditions, severe hepatic impairment, or hypersensitivity to Daunorubicin. It should be used with caution in patients with a history of radiation therapy or concurrent use of other cardiotoxic agents. Proper handling and disposal are essential, as Daunorubicin is a cytotoxic agent and poses risks to healthcare providers.



This medication is a critical component of many chemotherapy regimens, offering hope and improved outcomes for patients battling aggressive cancers. Always consult a healthcare professional for detailed guidance on its use, potential risks, and benefits.


  • Daunorubicin Hydrochloride

  • Sodium Chloride

  • Hydrochloric Acid (for pH adjustment)

  • Sodium Hydroxide (for pH adjustment)

  • Water for Injection

CERUBIDINE INJECTION (Daunorubicin 20mg/vial) is a chemotherapy medication used to treat certain types of leukemia. It should be administered under the supervision of a qualified healthcare professional in a clinical setting. Below are the detailed instructions for its proper use:




  1. Preparation:

    • Ensure the vial and diluent are at room temperature before preparation.

    • Reconstitute the 20mg vial with 4mL of sterile water for injection to achieve a concentration of 5mg/mL.

    • Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously.

    • Inspect the solution for discoloration or particles before use. The solution should be clear and red.




  2. Administration:

    • Calculate the correct dosage based on the patient's body surface area and treatment protocol.

    • Further dilute the reconstituted solution in 50-100mL of 0.9% sodium chloride injection or 5% dextrose injection.

    • Administer the infusion intravenously over 3-5 minutes or as per the physician's instructions.

    • Avoid extravasation, as it may cause severe tissue damage. Ensure proper needle placement before infusion.




  3. Precautions:

    • Wear gloves and protective clothing during preparation and administration to avoid skin contact.

    • Monitor the patient's cardiac function, blood counts, and liver/kidney function during treatment.

    • Dispose of unused medication and contaminated materials as per hazardous waste guidelines.

    • Do not mix CERUBIDINE with heparin or other drugs unless compatibility is confirmed.




  4. Storage:

    • Store unopened vials at controlled room temperature (20-25°C) and protect from light.

    • Use the reconstituted solution immediately or within 24 hours if stored under refrigeration (2-8°C).

    • Discard any unused portion of the diluted solution after 24 hours.





Patients should be closely monitored for adverse reactions such as bone marrow suppression, cardiotoxicity, or hypersensitivity. Hydration and antiemetic therapy may be required as supportive care. Always follow the specific protocol prescribed by the treating oncologist.

You may also like

100% Authentic

Our products are sourced directly from brands or authorized distributors.